295 related articles for article (PubMed ID: 30003315)
1. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study.
Yang J; Zhang Y; Sun X; Gusdon AM; Song N; Chen L; Jiang G; Huang Y
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1835-1842. PubMed ID: 30003315
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the Survival Time in the Non-small Cell Lung Cancer Patients with Different Organ Metastasis].
Wu B; Wei S; Tian J; Song X; Hu P; Cui Y
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):105-110. PubMed ID: 30827327
[TBL] [Abstract][Full Text] [Related]
6. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective.
Paralkar VR; Li T; Langer CJ
Clin Lung Cancer; 2008 Mar; 9(2):116-21. PubMed ID: 18501099
[TBL] [Abstract][Full Text] [Related]
7. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
8. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
[TBL] [Abstract][Full Text] [Related]
9. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study.
Hao Y; Li G
Eur J Cancer Prev; 2023 Sep; 32(5):498-511. PubMed ID: 36804864
[TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.
Ren Y; Dai C; Zheng H; Zhou F; She Y; Jiang G; Fei K; Yang P; Xie D; Chen C
Oncotarget; 2016 Aug; 7(33):53245-53253. PubMed ID: 27449299
[TBL] [Abstract][Full Text] [Related]
11. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
12. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
Zhang J; Gold KA; Lin HY; Swisher SG; Xing Y; Lee JJ; Kim ES; William WN
J Thorac Oncol; 2015 Apr; 10(4):682-90. PubMed ID: 25590605
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
15. Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis.
Zhang Y; Guo X; Wang G; Ma W; Liu R; Han X; Li L; Baklaushev VP; Bryukhovetskiy AS; Wang W; Wang X; Zhang C
Med Sci Monit; 2018 Sep; 24():6387-6397. PubMed ID: 30207328
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Surgery as Part of the Management of Metastatic Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results Database Analysis.
Abdel-Rahman O
Cancer Invest; 2018 Apr; 36(4):238-245. PubMed ID: 29775109
[TBL] [Abstract][Full Text] [Related]
17. The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
Chen J
PLoS One; 2018; 13(8):e0200909. PubMed ID: 30102707
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
[TBL] [Abstract][Full Text] [Related]
19. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):695-701. PubMed ID: 28276812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]